• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移行带中的睾酮和双氢睾酮水平与前列腺体积相关。

Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.

作者信息

Pejčić Tomislav, Tosti Tomislav, Tešić Živoslav, Milković Borivoj, Dragičević Dejan, Kozomara Milutin, Čekerevac Milica, Džamić Zoran

机构信息

Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia.

Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.

出版信息

Prostate. 2017 Jul;77(10):1082-1092. doi: 10.1002/pros.23365. Epub 2017 Jun 8.

DOI:10.1002/pros.23365
PMID:28594074
Abstract

BACKGROUND

There is still no consensus regarding intraprostatic androgen levels and the accumulation of androgens in the hyperplastic prostatic tissue. The current opinion is that intraprostatic dihydrotestosterone (DHT) concentrations are maintained but not elevated in benign prostatic hyperplasia (BPH), while there is no similar data concerning intraprostatic testosterone (T).

METHODS

Tissue T (tT) and tissue DHT (tDHT) concentration were determined in 93 patients scheduled for initial prostate biopsy. The criteria for biopsy were abnormal DRE and/or PSA > 4 ng/mL. Total prostate volume (TPV) was determined by transrectal ultrasound (TRUS). During TRUS- guided prostate biopsy, 10-12 samples were collected from the peripheral zone (PZ) and two additional samples were collected from the transition zone (TZ). The samples from the TZ were immediately frozen in liquid nitrogen at -70°C, and transported for tissue androgen determination, using liquid chromatography mass spectrometry (LC-MS).

RESULTS

Pathological analysis revealed that prostate cancer (PCa) was present in 45 and absent in 48 patients. In the whole group, there were 42 men with small prostate (TPV < 30 mL) and 51 with enlarged prostate (TPV ≥ 31 mL). The overall average tT level was 0.79 ± 0.66 ng/g, while the average tDHT level was 10.27 ± 7.15 ng/g. There were no differences in tT and tDHT level in prostates with and without PCa. However, tT and tDHT levels were significantly higher in larger, than in smaller prostates (tT: 1.05 ± 0.75 and 0.46 ± 0.29 ng/g, and tDHT: 15.0 ± 6.09 and 4.51 ± 2.75 ng/g, respectively). There were strong correlations between tT and TPV (r = 0.71), and tDHT and TPV (r = 0.74).

CONCLUSIONS

The present study confirmed that both T and DHT accumulated in the stroma of enlarged prostates; the degree of accumulation correlated with prostate volume.

摘要

背景

关于前列腺内雄激素水平以及雄激素在增生性前列腺组织中的蓄积,目前仍未达成共识。目前的观点是,在良性前列腺增生(BPH)中,前列腺内双氢睾酮(DHT)浓度保持不变但并未升高,而关于前列腺内睾酮(T)则没有类似数据。

方法

对93例计划进行初次前列腺活检的患者测定组织T(tT)和组织DHT(tDHT)浓度。活检标准为直肠指检异常和/或前列腺特异抗原(PSA)>4 ng/mL。经直肠超声(TRUS)测定前列腺总体积(TPV)。在TRUS引导下进行前列腺活检时,从外周区(PZ)采集10 - 12个样本,从移行区(TZ)额外采集2个样本。TZ的样本立即在液氮中于-70°C冷冻,并使用液相色谱质谱联用仪(LC-MS)运送进行组织雄激素测定。

结果

病理分析显示,45例患者存在前列腺癌(PCa),48例患者不存在。在整个组中,有42名男性前列腺较小(TPV<30 mL),51名男性前列腺增大(TPV≥31 mL)。总体平均tT水平为0.79±0.66 ng/g,而平均tDHT水平为10.27±7.15 ng/g。有PCa和无PCa的前列腺组织中tT和tDHT水平无差异。然而,较大前列腺组织中的tT和tDHT水平显著高于较小前列腺组织(tT分别为1.05±0.75和0.46±0.29 ng/g,tDHT分别为15.0±6.09和4.51±2.75 ng/g)。tT与TPV(r = 0.71)以及tDHT与TPV(r = 0.74)之间存在强相关性。

结论

本研究证实,T和DHT均在增大的前列腺基质中蓄积;蓄积程度与前列腺体积相关。

相似文献

1
Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.移行带中的睾酮和双氢睾酮水平与前列腺体积相关。
Prostate. 2017 Jul;77(10):1082-1092. doi: 10.1002/pros.23365. Epub 2017 Jun 8.
2
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.非那雄胺对良性前列腺增生组织雄激素浓度的差异作用。
Clin Endocrinol (Oxf). 1997 Feb;46(2):137-44. doi: 10.1046/j.1365-2265.1997.950908.x.
3
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.前列腺内的睾酮和二氢睾酮。第一部分:良性前列腺增生和前列腺癌患者中的浓度和测定方法。
BJU Int. 2012 Jan;109(2):176-82. doi: 10.1111/j.1464-410X.2011.10651.x. Epub 2011 Oct 12.
4
High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.采用超灵敏液相色谱-串联质谱法检测的高血清双氢睾酮作为前列腺特异性抗原水平为3-10 ng/mL男性良性前列腺增生或Gleason评分6分癌症的预测指标。
Andrology. 2017 Mar;5(2):262-267. doi: 10.1111/andr.12294. Epub 2016 Nov 3.
5
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).人癌前列腺组织及血清中的性激素(STERKPROSER 试验)
Prostate. 2019 Feb;79(3):272-280. doi: 10.1002/pros.23732. Epub 2018 Oct 28.
6
The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.度他雄胺对良性前列腺增生男性患者前列腺内二氢睾酮浓度的影响。
Prostate Cancer Prostatic Dis. 2007;10(2):149-54. doi: 10.1038/sj.pcan.4500931. Epub 2006 Dec 26.
7
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.良性前列腺增生组织中胰岛素样生长因子I(IGF-I)、IGF-II及I型受体的区域差异及其与前列腺内雄激素的相关性。
J Clin Endocrinol Metab. 2001 Apr;86(4):1700-6. doi: 10.1210/jcem.86.4.7413.
8
Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.血清二氢睾酮水平与 40-79 岁台湾男性前列腺体积之间存在显著关联。
Aging Male. 2012 Mar;15(1):28-33. doi: 10.3109/13685538.2010.550660. Epub 2011 Jan 19.
9
Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.良性前列腺增生症和前列腺癌中主要雄激素的组织和血清水平。
Steroids. 2007 Apr;72(4):375-80. doi: 10.1016/j.steroids.2007.01.004. Epub 2007 Feb 13.
10
Effects of steroids on oxytocin secretion by the human prostate in vitro.类固醇对人前列腺体外催产素分泌的影响。
Int J Androl. 2004 Feb;27(1):12-8. doi: 10.1111/j.1365-2605.2004.00439.x.

引用本文的文献

1
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptoms.为下尿路症状患者量身定制前列腺癌体外放射治疗
World J Urol. 2025 Jun 7;43(1):361. doi: 10.1007/s00345-025-05730-1.
2
Effect of Proanthocyanidins from Grape Seed Extract on Benign Prostatic Hyperplasia.葡萄籽提取物中原花青素对良性前列腺增生的影响。
Nutrients. 2024 Dec 28;17(1):73. doi: 10.3390/nu17010073.
3
The Association Between Solid Fuel Use and Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Sichuan, China: Cross-Sectional Study.
固体燃料使用与中国四川良性前列腺增生症下尿路症状的相关性:横断面研究。
JMIR Public Health Surveill. 2024 Oct 31;10:e53673. doi: 10.2196/53673.
4
Selenium in combination with a tomato lipid extract as a therapy for benign prostatic hyperplasia and its alterations in rats with induced BPH.硒与番茄脂质提取物联合用于治疗良性前列腺增生及其对诱导性良性前列腺增生大鼠的影响。
J Cell Mol Med. 2023 Oct;27(20):3147-3156. doi: 10.1111/jcmm.17903. Epub 2023 Sep 19.
5
Association between sleep quality and benign prostate hyperplasia among middle-aged and older men in India.印度中老年男性睡眠质量与良性前列腺增生的关系。
BMC Public Health. 2023 Jun 14;23(1):1147. doi: 10.1186/s12889-023-15972-6.
6
Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size.长期睾酮治疗(TTh)可改善性腺功能低下男性的排尿功能,与前列腺体积无关。
Int Urol Nephrol. 2023 Jul;55(7):1649-1658. doi: 10.1007/s11255-023-03602-4. Epub 2023 May 6.
7
A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia.对良性前列腺增生中炎症细胞因子免疫相关相互作用的新见解
J Clin Med. 2023 Feb 24;12(5):1821. doi: 10.3390/jcm12051821.
8
The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer.异黄酮在预防乳腺癌和前列腺癌中的作用。
Antioxidants (Basel). 2023 Feb 3;12(2):368. doi: 10.3390/antiox12020368.
9
Association of sleep quality with lower urinary tract symptoms/benign prostatic hyperplasia among men in China: A cross-sectional study.中国男性睡眠质量与下尿路症状/良性前列腺增生的关联:一项横断面研究。
Front Aging Neurosci. 2022 Oct 24;14:938407. doi: 10.3389/fnagi.2022.938407. eCollection 2022.
10
The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis.度他雄胺和非那雄胺治疗良性前列腺增生症患者的疗效与安全性:一项系统评价和荟萃分析。
Transl Androl Urol. 2022 Mar;11(3):313-324. doi: 10.21037/tau-22-58.